Durvalumab as Consolidation Therapy in Patients With LS-SCLC Following sCRT
Clinical trial NCT07309211 · RECRUITING
Trial details
- NCT number
- NCT07309211
- Sponsor
- The First Affiliated Hospital with Nanjing Medical University
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2025-07-08
- Primary completion
- 2025-12-01
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.